Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
The Oncologist|July 4, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN studyAndrew J Wagner, William D Tap, Sebastian Bauer, et al.
Targeted Oncology|February 4, 2025
Checkpoint Inhibition Prior to Stem Cell Transplantation Increases the Risk of Inflammatory Adverse EventsMalek Shatila, Antonio Pizuorno Machado, Jay Shah, et al.
European Journal of Immunology|April 23, 2024
Temporal associations of plasma levels of the secreted phospholipase A2 family and mortality in severe COVID-19Eric Lu, Aki Hara, Shudong Sun, et al.
Medrxiv : the Preprint Server for Health Sciences|December 1, 2022
Temporal Associations of Plasma Levels of the Secreted Phospholipase A 2 Family and Mortality in Severe COVID-19Eric Lu, Aki Hara, Shudong Sun, et al.
NPJ Precision Oncology|January 24, 2025
Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinomaSandip P Patel, Eleanor Cano-Linson, Young Kwang Chae, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancerMary-Ellen Taplin, Meredith M Regan, Yoo-Joung Ko, et al.
Cancer|June 8, 2019
Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcomaShreyaskumar Patel, Margaret von Mehren, Damon R Reed, et al.
Cancer Communications (London, England)|May 22, 2025
A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohortYoung Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2020
Structural instability and divergence from conserved residues underlie intracellular retention of mammalian odorant receptorsKentaro Ikegami, Claire A de March, Maira H Nagai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlatesJanelle M Meyer, Kelly S Perlewitz, James B Hayden, et al.
Pageof 15